Scalp blood vessels and hair follicle cells

Scalp blood vessels and hair follicle cells represent a complex anatomical and physiological system rather than a single molecular target. The hair follicle is a self-renewing organ that relies on a specialized vascular bed, the perifollicular plexus, to provide nutrients and signaling molecules necessary for the hair growth cycle (StatPearls, 2023). Pharmacological intervention in this area typically aims to treat hair loss disorders like androgenetic alopecia by either increasing blood flow to the follicle or inhibiting the miniaturization of the follicle caused by androgens (Journal of Investigative Dermatology, 2018). Key molecular targets within these tissues include ATP-sensitive potassium channels in vascular smooth muscle and 5-alpha reductase enzymes within the follicular cells (PubChem, 2024). For instance, minoxidil promotes hair growth by inducing vasodilation and prolonging the anagen phase, while finasteride reduces levels of dihydrotestosterone, a potent androgen that triggers follicle shrinkage (FDA, 2021). Because this target encompasses multiple cell types and distinct biochemical pathways, it is characterized as a therapeutic site or tissue system rather than a discrete protein target.

Other names

Scalp vasculaturePilosebaceous unitHair follicle unitPerifollicular microvessels

Drugs targeting this system function through various mechanisms, including the opening of ATP-sensitive potassium channels to induce vasodilation (Minoxidil) and the inhibition of 5-alpha reductase to reduce dihydrotestosterone levels (Finasteride).